Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shudo

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Journal of Cardiovascular Development and Disease|November 20, 2020
A Bioengineered Neuregulin-Hydrogel Therapy Reduces Scar Size and Enhances Post-Infarct Ventricular Contractility in an Ovine Large Animal ModelJeffrey E Cohen, Andrew B Goldstone, Hanjay Wang, et al.
Immunity, Inflammation and Disease|September 5, 2025
Safety and 1-Year Outcomes After Transplanting Hearts From SARS-CoV-2 Positive Donors: Insights From an International AnalysisSabina P W Guenther, Josephine Wadewitz, Brian J Wayda, et al.
Cardiovascular Diabetology|November 4, 2017
Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathyMasashi Kawamura, Michael J Paulsen, Andrew B Goldstone, et al.
Journal of the American Heart Association|November 3, 2025
Dual Contrast-Enhanced Microcomputed Tomography Uncovers Leaflet-Dependent Patterns of Macrocalcification, Fibrous Extracellular Matrix Remodeling, and Adipocyte Degeneration in Calcific Aortic StenosisMustapha El Zeini, Ines Ross Tacco, John I Jimenez, et al.
Tissue Engineering. Part A|July 9, 2015
A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic CardiomyopathyYasuhiro Shudo, Jeffrey E Cohen, John W MacArthur, et al.
Clinical Transplantation|June 19, 2025
Which Donor and Recipient Risk Factors Matter in Heart Transplantation? Results From a Survey of 53 Centers Across Five CountriesSabina P W Guenther, René Schramm, Jeffrey J Teuteberg, et al.
Scientific Reports|October 20, 2022
Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodelingHye Sook Shin, Akshara Thakore, Yuko Tada, et al.
Circulation. Heart Failure|June 7, 2014
A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathyJeffrey E Cohen, Brendan P Purcell, John W MacArthur, et al.
Nature Communications|September 1, 2021
Predicting post-operative right ventricular failure using video-based deep learningRohan Shad, Nicolas Quach, Robyn Fong, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 2024
Four decades of progress in heart-lung transplantation: Two hundred seventy-one cases at a single institutionStefan Elde, Basil M Baccouche, Danielle M Mullis, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Journal of Cardiovascular Development and Disease|November 20, 2020
A Bioengineered Neuregulin-Hydrogel Therapy Reduces Scar Size and Enhances Post-Infarct Ventricular Contractility in an Ovine Large Animal ModelJeffrey E Cohen, Andrew B Goldstone, Hanjay Wang, et al.
Immunity, Inflammation and Disease|September 5, 2025
Safety and 1-Year Outcomes After Transplanting Hearts From SARS-CoV-2 Positive Donors: Insights From an International AnalysisSabina P W Guenther, Josephine Wadewitz, Brian J Wayda, et al.
Cardiovascular Diabetology|November 4, 2017
Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathyMasashi Kawamura, Michael J Paulsen, Andrew B Goldstone, et al.
Journal of the American Heart Association|November 3, 2025
Dual Contrast-Enhanced Microcomputed Tomography Uncovers Leaflet-Dependent Patterns of Macrocalcification, Fibrous Extracellular Matrix Remodeling, and Adipocyte Degeneration in Calcific Aortic StenosisMustapha El Zeini, Ines Ross Tacco, John I Jimenez, et al.
Tissue Engineering. Part A|July 9, 2015
A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic CardiomyopathyYasuhiro Shudo, Jeffrey E Cohen, John W MacArthur, et al.
Clinical Transplantation|June 19, 2025
Which Donor and Recipient Risk Factors Matter in Heart Transplantation? Results From a Survey of 53 Centers Across Five CountriesSabina P W Guenther, René Schramm, Jeffrey J Teuteberg, et al.
Scientific Reports|October 20, 2022
Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodelingHye Sook Shin, Akshara Thakore, Yuko Tada, et al.
Circulation. Heart Failure|June 7, 2014
A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathyJeffrey E Cohen, Brendan P Purcell, John W MacArthur, et al.
Nature Communications|September 1, 2021
Predicting post-operative right ventricular failure using video-based deep learningRohan Shad, Nicolas Quach, Robyn Fong, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 6, 2024
Four decades of progress in heart-lung transplantation: Two hundred seventy-one cases at a single institutionStefan Elde, Basil M Baccouche, Danielle M Mullis, et al.
Pageof 15